Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126269811 | 12626981 | 1 | I | 20160727 | 20160805 | 20160805 | EXP | FR-MYLANLABS-2016M1031695 | MYLAN | THOREL M, FUMMI C, GRAS V, MASMOUDI K. BENZODIAZEPINE OR NON-BENZODIAZEPINE HYPNOTICS WITHDRAWAL SYNDROME DURING HOSPITALIZATION: A SERIES OF 22 CASES. THERAPIE 2016;71(3):323-328. | 0.00 | Y | 0.00000 | 20160805 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126269811 | 12626981 | 1 | PS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0.125 MG | 74215 | ||||||||||
| 126269811 | 12626981 | 2 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126269811 | 12626981 | 1 | Product used for unknown indication |
| 126269811 | 12626981 | 2 | Psychotherapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126269811 | 12626981 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126269811 | 12626981 | Drug withdrawal syndrome | |
| 126269811 | 12626981 | Intentional product misuse | |
| 126269811 | 12626981 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |